These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 27471839)
1. A Highly Predictive Model for Diagnosis of Colorectal Neoplasms Using Plasma MicroRNA: Improving Specificity and Sensitivity. Carter JV; Roberts HL; Pan J; Rice JD; Burton JF; Galbraith NJ; Eichenberger MR; Jorden J; Deveaux P; Farmer R; Williford A; Kanaan Z; Rai SN; Galandiuk S Ann Surg; 2016 Oct; 264(4):575-84. PubMed ID: 27471839 [TBL] [Abstract][Full Text] [Related]
2. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer. Kanaan Z; Roberts H; Eichenberger MR; Billeter A; Ocheretner G; Pan J; Rai SN; Jorden J; Williford A; Galandiuk S Ann Surg; 2013 Sep; 258(3):400-8. PubMed ID: 24022433 [TBL] [Abstract][Full Text] [Related]
3. A plasma microRNA panel for early detection of colorectal cancer. Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911 [TBL] [Abstract][Full Text] [Related]
4. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer. Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702 [TBL] [Abstract][Full Text] [Related]
5. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer. Luo X; Wu Y; Ji M; Zhang S Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212 [TBL] [Abstract][Full Text] [Related]
6. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer. Wang Q; Huang Z; Ni S; Xiao X; Xu Q; Wang L; Huang D; Tan C; Sheng W; Du X PLoS One; 2012; 7(9):e44398. PubMed ID: 22970209 [TBL] [Abstract][Full Text] [Related]
7. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer. Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602 [TBL] [Abstract][Full Text] [Related]
8. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study. Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection. Chang PY; Chen CC; Chang YS; Tsai WS; You JF; Lin GP; Chen TW; Chen JS; Chan EC Oncotarget; 2016 Mar; 7(9):10663-75. PubMed ID: 26848774 [TBL] [Abstract][Full Text] [Related]
10. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Huang Z; Huang D; Ni S; Peng Z; Sheng W; Du X Int J Cancer; 2010 Jul; 127(1):118-26. PubMed ID: 19876917 [TBL] [Abstract][Full Text] [Related]
11. Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients. Du M; Liu S; Gu D; Wang Q; Zhu L; Kang M; Shi D; Chu H; Tong N; Chen J; Adams TS; Zhang Z; Wang M Carcinogenesis; 2014 Dec; 35(12):2723-30. PubMed ID: 25239640 [TBL] [Abstract][Full Text] [Related]
12. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma. Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223 [TBL] [Abstract][Full Text] [Related]
13. Plasma miR-21: a potential diagnostic marker of colorectal cancer. Kanaan Z; Rai SN; Eichenberger MR; Roberts H; Keskey B; Pan J; Galandiuk S Ann Surg; 2012 Sep; 256(3):544-51. PubMed ID: 22868372 [TBL] [Abstract][Full Text] [Related]
14. Identification and evaluation of plasma microRNAs for early detection of colorectal cancer. Luo X; Stock C; Burwinkel B; Brenner H PLoS One; 2013; 8(5):e62880. PubMed ID: 23690963 [TBL] [Abstract][Full Text] [Related]
15. Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer. Herreros-Villanueva M; Duran-Sanchon S; Martín AC; Pérez-Palacios R; Vila-Navarro E; Marcuello M; Diaz-Centeno M; Cubiella J; Diez MS; Bujanda L; Lanas A; Jover R; Hernández V; Quintero E; José Lozano J; García-Cougil M; Martínez-Arranz I; Castells A; Gironella M; Arroyo R Clin Transl Gastroenterol; 2019 Jan; 10(1):e00003. PubMed ID: 30702491 [TBL] [Abstract][Full Text] [Related]
16. Identification of microRNA-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenoma. Wu CW; Ng SC; Dong Y; Tian L; Ng SS; Leung WW; Law WT; Yau TO; Chan FK; Sung JJ; Yu J Clin Cancer Res; 2014 Jun; 20(11):2994-3002. PubMed ID: 24691020 [TBL] [Abstract][Full Text] [Related]
17. The ratio of miR-21/miR-24 as a promising diagnostic and poor prognosis biomarker in colorectal cancer. Hao JP; Ma A Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8649-8656. PubMed ID: 30575905 [TBL] [Abstract][Full Text] [Related]
18. Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia. Yamada A; Horimatsu T; Okugawa Y; Nishida N; Honjo H; Ida H; Kou T; Kusaka T; Sasaki Y; Yagi M; Higurashi T; Yukawa N; Amanuma Y; Kikuchi O; Muto M; Ueno Y; Nakajima A; Chiba T; Boland CR; Goel A Clin Cancer Res; 2015 Sep; 21(18):4234-42. PubMed ID: 26038573 [TBL] [Abstract][Full Text] [Related]
19. Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis. Carter JV; Galbraith NJ; Yang D; Burton JF; Walker SP; Galandiuk S Br J Cancer; 2017 Mar; 116(6):762-774. PubMed ID: 28152545 [TBL] [Abstract][Full Text] [Related]
20. Circulating plasma microRNAs in colorectal neoplasia: A pilot study in assessing response to therapy. O'Brien SJ; Netz U; Hallion J; Bishop C; Stephen V; Burton J; Paas M; Feagins K; Pan J; Rai SN; Galandiuk S Transl Oncol; 2021 Jan; 14(1):100962. PubMed ID: 33285367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]